+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
GMP Cell Banking Services Market - Global Forecast 2026-2032- Product Image
GMP Cell Banking Services Market - Global Forecast 2026-2032- Product Image
Sale

GMP Cell Banking Services Market - Global Forecast 2026-2032

  • Report

  • 199 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6055130
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The GMP Cell Banking Services Market is projected to reach USD 1.24 Billion in 2026. It is expected to continue growing at a CAGR of 12.51%, reaching USD 2.54 Billion by 2032.

GMP Cell Banking Services: Executive Overview

GMP cell banking services support the controlled creation, characterization, storage, and lifecycle management of cell banks used in regulated biopharmaceutical development and manufacturing. Their importance is rising as therapies become more cell-based, manufacturing processes become more complex, and regulators place greater emphasis on traceability, contamination control, comparability, and reproducibility. The service landscape spans master and working cell banks, microbial and mammalian systems, identity and purity testing, stability programs, cryogenic storage, documentation, and technology-transfer support.

Regulatory Complexity Is Reshaping Cell Banking Operations

The landscape is shifting from stand-alone cell preservation toward integrated, risk-based lifecycle management. Sponsors increasingly require documented chain of custody, qualified facilities, validated analytical methods, robust deviation management, and continuity plans for critical biological materials. Demand is also being shaped by more diverse modalities, tighter expectations for raw-material control, and the need to demonstrate consistency across development, clinical, and commercial stages. Providers that combine technical depth with strong quality systems are better positioned to support complex programs and inspections.

Artificial Intelligence Strengthens Quality, Traceability, and Planning

Artificial intelligence is contributing to GMP cell banking through anomaly detection, trend analysis, electronic record review, inventory reconciliation, and predictive maintenance of storage infrastructure. Machine-learning tools can help prioritize investigations, identify unusual environmental or viability patterns, and improve scheduling of testing and cryogenic operations. However, AI-generated outputs require validated intended-use definitions, controlled data inputs, audit trails, human oversight, and cybersecurity safeguards. Its cumulative impact is therefore most credible when applied as a governed decision-support layer rather than as an autonomous replacement for quality professionals.

Regional Insights: Regulatory Maturity and Manufacturing Depth Differ

North America benefits from advanced biopharmaceutical infrastructure and strong demand for compliant cell-banking capacity. Europe combines mature quality expectations with cross-border regulatory coordination, while the European Union places particular emphasis on harmonized documentation and data integrity. Asia-Pacific is expanding technical capabilities across established and emerging manufacturing hubs, supported by growing biologics activity. Latin America is developing localized production and regulatory capacity, although access to specialized infrastructure can vary. The Middle East is investing in life-science capabilities and strategic supply resilience, while Africa remains an emerging landscape where workforce development, infrastructure, and regulatory strengthening are central priorities.

Group Insights: Alliances Shape Standards and Supply Resilience

ASEAN economies are building regional biopharmaceutical capabilities while navigating differing regulatory systems and infrastructure maturity. BRICS members reflect a broad mix of manufacturing strengths, domestic healthcare priorities, and localization objectives. The European Union emphasizes regulatory alignment and cross-border quality consistency. G7 countries generally combine advanced research ecosystems with mature inspection and compliance frameworks. GCC markets are strengthening healthcare and biotechnology infrastructure, with an emphasis on strategic capability development. NATO countries collectively include major research and manufacturing centers, making resilience, secure logistics, and continuity planning relevant to cell-bank operations.

Country Insights: Capabilities Range from Established Hubs to Developing Systems

The United States and Canada have mature biopharmaceutical ecosystems and extensive experience with regulated cell-banking programs. The United Kingdom, Germany, France, Italy, and Spain operate within highly developed European research and quality environments, with strong emphasis on documentation and regulatory compliance. Japan and South Korea combine advanced manufacturing capabilities with sophisticated quality systems, while China is expanding domestic biopharmaceutical capacity and regulatory infrastructure. India is strengthening biologics manufacturing and analytical capabilities. Australia supports specialized research and regulated manufacturing activity. Brazil and Mexico are developing regional life-science capacity, while Russia’s landscape is influenced by domestic production priorities and changing international access conditions.

Actionable Priorities for Industry Leaders

Industry leaders should define cell-bank requirements early, including intended use, acceptance criteria, testing strategy, storage duration, and transfer responsibilities. They should qualify suppliers through facility audits, quality agreements, data-integrity reviews, personnel assessments, and evidence of validated methods. Dual-site or contingency planning can reduce exposure to equipment failure, logistics disruption, and single-source dependencies. Leaders should also establish clear governance for AI-enabled tools, including validation, access controls, model monitoring, and human approval. Finally, programs should align regulatory, manufacturing, analytical, and quality teams around a single lifecycle record for every cell bank.

Research Methodology: Evidence-Based Market Interpretation

This executive summary applies a structured qualitative review of GMP cell banking services, focusing on service scope, regulatory drivers, technology adoption, operating requirements, and geographic capability. Insights are organized across required regions, economic and political groups, and countries to identify differences in infrastructure, compliance maturity, and strategic priorities. Claims are limited to broadly verifiable industry characteristics and avoid unsupported numerical estimates, forecasts, market shares, and company-specific assertions. The analysis also treats artificial intelligence as an enabling technology whose value depends on validation, governance, data quality, and appropriate human oversight.

Conclusion: Quality Systems and Resilience Define Competitive Readiness

GMP cell banking services are becoming a foundational component of reliable cell-based development and manufacturing. Success depends on more than cryogenic storage: it requires controlled processes, defensible testing, complete traceability, resilient infrastructure, and regulatory readiness across the entire cell-bank lifecycle. Regional and national capabilities will continue to differ, but organizations that integrate quality, technology, continuity planning, and transparent supplier governance will be best prepared to support increasingly complex biological programs.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. GMP Cell Banking Services Market, by Service Type
7.1. Introduction
7.2. Cell Banking & Storage
7.3. Cell Line Development & Characterization
7.4. Regulatory Support & Documentation
7.5. Testing & Quality Control
7.5.1. Adventitious Agent Testing
7.5.2. Genetic Stability Testing
7.5.3. Identity Testing
7.5.4. Purity Testing
7.5.5. Sterility Testing
8. GMP Cell Banking Services Market, by Cell Type
8.1. Introduction
8.2. Insect Cells
8.3. Mammalian Cells
8.3.1. CHO Cells
8.3.2. HEK293 Cells
8.3.3. NS0/Sp2 Cells
8.3.4. Vero Cells
8.4. Microbial Cells
8.4.1. Bacterial Cells
8.4.2. Yeast Cells
8.5. Stem Cells
8.5.1. Embryonic Stem Cells
8.5.2. Induced Pluripotent Stem Cells (iPSCs)
8.5.3. Mesenchymal Stem Cells (MSCs)
9. GMP Cell Banking Services Market, by Cell Bank Type
9.1. Introduction
9.2. End-of-Production Cell Bank (EOPCB)
9.3. Master Cell Bank (MCB)
9.4. Research Cell Bank (RCB)
9.5. Working Cell Bank (WCB)
10. GMP Cell Banking Services Market, by Application
10.1. Introduction
10.2. Biopharmaceutical Production
10.2.1. Gene & Cell Therapies
10.2.2. Monoclonal Antibodies
10.2.3. Recombinant Proteins
10.2.4. Vaccines
10.3. Cell Therapy
10.4. Drug Discovery & Development
10.5. Tissue Engineering & Regenerative Medicine
11. GMP Cell Banking Services Market, by End User
11.1. Introduction
11.2. Academic & Research Institutes
11.3. Contract Research & Manufacturing Organizations
11.4. Hospitals & Clinics
11.5. Pharmaceutical & Biotechnology Companies
12. GMP Cell Banking Services Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. GMP Cell Banking Services Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. GMP Cell Banking Services Market, by Country
14.1. Introduction
14.2. United States
14.3. Germany
14.4. China
14.5. India
14.6. Japan
14.7. United Kingdom
14.8. Canada
14.9. Russia
14.10. Brazil
14.11. Italy
14.12. Mexico
14.13. France
14.14. Spain
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. 53Biologics
16.2. Austrianova
16.3. Cell Culture Company, LLC
16.4. Charles River Laboratories
16.5. Clean Cells
16.6. Eurofins Scientific Limited
16.7. ExcellGene SA
16.8. eXmoor pharma concepts ltd
16.9. Goodwin Biotechnology Inc.
16.10. Kaneka Eurogentec S.A.
16.11. Lonza Group Ltd.
16.12. Merck KGaA
16.13. NAOBIOS
16.14. OmniaBio
16.15. PackGene Biotech lnc.
16.16. ProBio Biotech Corporation
16.17. RoslinCT
16.18. SGS Group
16.19. SK pharmteco Inc.
16.20. Takara Bio Inc.
16.21. Texcell SA
16.22. uBriGene Biosciences International Co.
16.23. ViruSure GmbH
16.24. Wacker Chemie AG
16.25. WuXi Biologics
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global GMP Cell Banking Services Market, Years Considered for the Study
FIGURE 2. Global GMP Cell Banking Services Market, Research Design
FIGURE 3. Global GMP Cell Banking Services Market, Research Framework
FIGURE 4. Global GMP Cell Banking Services Market, Data Triangulation
FIGURE 5. Global GMP Cell Banking Services Market Size, 2017-2032 (USD Million)
FIGURE 6. Global GMP Cell Banking Services Market Size, by Service Type, 2025 vs 2032 (%)
FIGURE 7. Global GMP Cell Banking Services Market Size, by Service Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global GMP Cell Banking Services Market Size, by Cell Type, 2025 vs 2032 (%)
FIGURE 9. Global GMP Cell Banking Services Market Size, by Cell Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global GMP Cell Banking Services Market Size, by Cell Bank Type, 2025 vs 2032 (%)
FIGURE 11. Global GMP Cell Banking Services Market Size, by Cell Bank Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global GMP Cell Banking Services Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global GMP Cell Banking Services Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global GMP Cell Banking Services Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global GMP Cell Banking Services Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global GMP Cell Banking Services Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global GMP Cell Banking Services Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global GMP Cell Banking Services Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global GMP Cell Banking Services Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global GMP Cell Banking Services Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global GMP Cell Banking Services Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global GMP Cell Banking Services Market Segmentation & Coverage
TABLE 2. Global GMP Cell Banking Services Market Size, 2017-2032 (USD Million)
TABLE 3. Global GMP Cell Banking Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 4. Global Cell Banking & Storage Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Cell Banking & Storage Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Cell Banking & Storage Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Cell Line Development & Characterization Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Cell Line Development & Characterization Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Cell Line Development & Characterization Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Regulatory Support & Documentation Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Regulatory Support & Documentation Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Regulatory Support & Documentation Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Testing & Quality Control Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Testing & Quality Control Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Testing & Quality Control Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Adventitious Agent Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Adventitious Agent Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Adventitious Agent Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Genetic Stability Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Genetic Stability Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Genetic Stability Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Identity Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Identity Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Identity Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Purity Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Purity Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Purity Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Sterility Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Sterility Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Sterility Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global GMP Cell Banking Services Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 32. Global Insect Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Insect Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Insect Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Mammalian Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Mammalian Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Mammalian Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global CHO Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global CHO Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global CHO Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global HEK293 Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global HEK293 Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global HEK293 Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global NS0/Sp2 Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global NS0/Sp2 Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global NS0/Sp2 Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Vero Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Vero Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Vero Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Microbial Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Microbial Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Microbial Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Bacterial Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Bacterial Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Bacterial Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Yeast Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Yeast Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Yeast Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Stem Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Stem Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Stem Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Embryonic Stem Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Embryonic Stem Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Embryonic Stem Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Induced Pluripotent Stem Cells (iPSCs) Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Induced Pluripotent Stem Cells (iPSCs) Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Induced Pluripotent Stem Cells (iPSCs) Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Mesenchymal Stem Cells (MSCs) Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Mesenchymal Stem Cells (MSCs) Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Mesenchymal Stem Cells (MSCs) Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global GMP Cell Banking Services Market Size, by Cell Bank Type, 2017-2032 (USD Million)
TABLE 72. Global End-of-Production Cell Bank (EOPCB) Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global End-of-Production Cell Bank (EOPCB) Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global End-of-Production Cell Bank (EOPCB) Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Master Cell Bank (MCB) Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Master Cell Bank (MCB) Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Master Cell Bank (MCB) Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Research Cell Bank (RCB) Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Research Cell Bank (RCB) Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Research Cell Bank (RCB) Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Working Cell Bank (WCB) Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Working Cell Bank (WCB) Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Working Cell Bank (WCB) Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global GMP Cell Banking Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 85. Global Biopharmaceutical Production Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Biopharmaceutical Production Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Biopharmaceutical Production Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Gene & Cell Therapies Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global Gene & Cell Therapies Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global Gene & Cell Therapies Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global Monoclonal Antibodies Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global Monoclonal Antibodies Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global Monoclonal Antibodies Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global Recombinant Proteins Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global Recombinant Proteins Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global Recombinant Proteins Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Cell Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Cell Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Cell Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Drug Discovery & Development Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Drug Discovery & Development Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Drug Discovery & Development Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global Tissue Engineering & Regenerative Medicine Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global Tissue Engineering & Regenerative Medicine Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global Tissue Engineering & Regenerative Medicine Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global GMP Cell Banking Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 110. Global Academic & Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 111. Global Academic & Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. Global Academic & Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 113. Global Contract Research & Manufacturing Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Global Contract Research & Manufacturing Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. Global Contract Research & Manufacturing Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 116. Global Hospitals & Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Global Hospitals & Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. Global Hospitals & Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 119. Global Pharmaceutical & Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Global Pharmaceutical & Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. Global Pharmaceutical & Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 122. Global GMP Cell Banking Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Asia-Pacific GMP Cell Banking Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 124. Asia-Pacific GMP Cell Banking Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 125. Asia-Pacific GMP Cell Banking Services Market Size, by Testing & Quality Control, 2017-2032 (USD Million)
TABLE 126. Asia-Pacific GMP Cell Banking Services Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 127. Asia-Pacific GMP Cell Banking Services Market Size, by Mammalian Cells, 2017-2032 (USD Million)
TABLE 128. Asia-Pacific GMP Cell Banking Services Market Size, by Microbial Cells, 2017-2032 (USD Million)
TABLE 129. Asia-Pacific GMP Cell Banking Services Market Size, by Stem Cells, 2017-2032 (USD Million)
TABLE 130. Asia-Pacific GMP Cell Banking Services Market Size, by Cell Bank Type, 2017-2032 (USD Million)
TABLE 131. Asia-Pacific GMP Cell Banking Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 132. Asia-Pacific GMP Cell Banking Services Market Size, by Biopharmaceutical Production, 2017-2032 (USD Million)
TABLE 133. Asia-Pacific GMP Cell Banking Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 134. North America GMP Cell Banking Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 135. North America GMP Cell Banking Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 136. North America GMP Cell Banking Services Market Size, by Testing & Quality Control, 2017-2032 (USD Million)
TABLE 137. North America GMP Cell Banking Services Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 138. North America GMP Cell Banking Services Market Size, by Mammalian Cells, 2017-2032 (USD Million)
TABLE 139. North America GMP Cell Banking Services Market Size, by Microbial Cells, 2017-2032 (USD Million)
TABLE 140. North America GMP Cell Banking Services Market Size, by Stem Cells, 2017-2032 (USD Million)
TABLE 141. North America GMP Cell Banking Services Market Size, by Cell Bank Type, 2017-2032 (USD Million)
TABLE 142. North America GMP Cell Banking Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 143. North America GMP Cell Banking Services Market Size, by Biopharmaceutical Production, 2017-2032 (USD Million)
TABLE 144. North America GMP Cell Banking Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 145. Latin America GMP Cell Banking Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 146. Latin America GMP Cell Banking Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 147. Latin America GMP Cell Banking Services Market Size, by Testing & Quality Control, 2017-2032 (USD Million)
TABLE 148. Latin America GMP Cell Banking Services Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 149. Latin America GMP Cell Banking Services Market Size, by Mammalian Cells, 2017-2032 (USD Million)
TABLE 150. Latin America GMP Cell Banking Services Market Size, by Microbial Cells, 2017-2032 (USD Million)
TABLE 151. Latin America GMP Cell Banking Services Market Size, by Stem Cells, 2017-2032 (USD Million)
TABLE 152. Latin America GMP Cell Banking Services Market Size, by Cell Bank Type, 2017-2032 (USD Million)
TABLE 153. Latin America GMP Cell Banking Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 154. Latin America GMP Cell Banking Services Market Size, by Biopharmaceutical Production, 2017-2032 (USD Million)
TABLE 155. Latin America GMP Cell Banking Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 156. Europe GMP Cell Banking Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 157. Europe GMP Cell Banking Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 158. Europe GMP Cell Banking Services Market Size, by Testing & Quality Control, 2017-2032 (USD Million)
TABLE 159. Europe GMP Cell Banking Services Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 160. Europe GMP Cell Banking Services Market Size, by Mammalian Cells, 2017-2032 (USD Million)
TABLE 161. Europe GMP Cell Banking Services Market Size, by Microbial Cells, 2017-2032 (USD Million)
TABLE 162. Europe GMP Cell Banking Services Market Size, by Stem Cells, 2017-2032 (USD Million)
TABLE 163. Europe GMP Cell Banking Services Market Size, by Cell Bank Type, 2017-2032 (USD Million)
TABLE 164. Europe GMP Cell Banking Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 165. Europe GMP Cell Banking Services Market Size, by Biopharmaceutical Production, 2017-2032 (USD Million)
TABLE 166. Europe GMP Cell Banking Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 167. Middle East GMP Cell Banking Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 168. Middle East GMP Cell Banking Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 169. Middle East GMP Cell Banking Services Market Size, by Testing & Quality Control, 2017-2032 (USD Million)
TABLE 170. Middle East GMP Cell Banking Services Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 171. Middle East GMP Cell Banking Services Market Size, by Mammalian Cells, 2017-2032 (USD Million)
TABLE 172. Middle East GMP Cell Banking Services Market Size, by Microbial Cells, 2017-2032 (USD Million)
TABLE 173. Middle East GMP Cell Banking Services Market Size, by Stem Cells, 2017-2032 (USD Million)
TABLE 174. Middle East GMP Cell Banking Services Market Size, by Cell Bank Type, 2017-2032 (USD Million)
TABLE 175. Middle East GMP Cell Banking Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 176. Middle East GMP Cell Banking Services Market Size, by Biopharmaceutical Production, 2017-2032 (USD Million)
TABLE 177. Middle East GMP Cell Banking Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 178. Africa GMP Cell Banking Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 179. Africa GMP Cell Banking Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 180. Africa GMP Cell Banking Services Market Size, by Testing & Quality Control, 2017-2032 (USD Million)
TABLE 181. Africa GMP Cell Banking Services Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 182. Africa GMP Cell Banking Services Market Size, by Mammalian Cells, 2017-2032 (USD Million)
TABLE 183. Africa GMP Cell Banking Services Market Size, by Microbial Cells, 2017-2032 (USD Million)
TABLE 184. Africa GMP Cell Banking Services Market Size, by Stem Cells, 2017-2032 (USD Million)
TABLE 185. Africa GMP Cell Banking Services Market Size, by Cell Bank Type, 2017-2032 (USD Million)
TABLE 186. Africa GMP Cell Banking Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 187. Africa GMP Cell Banking Services Market Size, by Biopharmaceutical Production, 2017-2032 (USD Million)
TABLE 188. Africa GMP Cell Banking Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 189. Global GMP Cell Banking Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 190. ASEAN GMP Cell Banking Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 191. ASEAN GMP Cell Banking Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 192. ASEAN GMP Cell Banking Services Market Size, by Testing & Quality Control, 2017-2032 (USD Million)
TABLE 193. ASEAN GMP Cell Banking Services Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 194. ASEAN GMP Cell Banking Services Market Size, by Mammalian Cells, 2017-2032 (USD Million)
TABLE 195. ASEAN GMP Cell Banking Services Market Size, by Microbial Cells, 2017-2032 (USD Million)
TABLE 196. ASEAN GMP Cell Banking Services Market Size, by Stem Cells, 2017-2032 (USD Million)
TABLE 197. ASEAN GMP Cell Banking Services Market Size, by Cell Bank Type, 2017-2032 (USD Million)
TABLE 198. ASEAN GMP Cell Banking Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 199. ASEAN GMP Cell Banking Services Market Size, by Biopharmaceutical Production, 2017-2032 (USD Million)
TABLE 200. ASEAN GMP Cell Banking Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 201. GCC GMP Cell Banking Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 202. GCC GMP Cell Banking Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 203. GCC GMP Cell Banking Services Market Size, by Testing & Quality Control, 2017-2032 (USD Million)
TABLE 204. GCC GMP Cell Banking Services Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 205. GCC GMP Cell Banking Services Market Size, by Mammalian Cells, 2017-2032 (USD Million)
TABLE 206. GCC GMP Cell Banking Services Market Size, by Microbial Cells, 2017-2032 (USD Million)
TABLE 207. GCC GMP Cell Banking Services Market Size, by Stem Cells, 2017-2032 (USD Million)
TABLE 208. GCC GMP Cell Banking Services Market Size, by Cell Bank Type, 2017-2032 (USD Million)
TABLE 209. GCC GMP Cell Banking Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 210. GCC GMP Cell Banking Services Market Size, by Biopharmaceutical Production, 2017-2032 (USD Million)
TABLE 211. GCC GMP Cell Banking Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 212. European Union GMP Cell Banking Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 213. European Union GMP Cell Banking Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 214. European Union GMP Cell Banking Services Market Size, by Testing & Quality Control, 2017-2032 (USD Million)
TABLE 215. European Union GMP Cell Banking Services Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 216. European Union GMP Cell Banking Services Market Size, by Mammalian Cells, 2017-2032 (USD Million)
TABLE 217. European Union GMP Cell Banking Services Market Size, by Microbial Cells, 2017-2032 (USD Million)
TABLE 218. European Union GMP Cell Banking Services Market Size, by Stem Cells, 2017-2032 (USD Million)
TABLE 219. European Union GMP Cell Banking Services Market Size, by Cell Bank Type, 2017-2032 (USD Million)
TABLE 220. European Union GMP Cell Banking Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 221. European Union GMP Cell Banking Services Market Size, by Biopharmaceutical Production, 2017-2032 (USD Million)
TABLE 222. European Union GMP Cell Banking Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 223. BRICS GMP Cell Banking Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 224. BRICS GMP Cell Banking Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 225. BRICS GMP Cell Banking Services Market Size, by Testing & Quality Control, 2017-2032 (USD Million)
TABLE 226. BRICS GMP Cell Banking Services Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 227. BRICS GMP Cell Banking Services Market Size, by Mammalian Cells, 2017-2032 (USD Million)
TABLE 228. BRICS GMP Cell Banking Services Market Size, by Microbial Cells, 2017-2032 (USD Million)
TABLE 229. BRICS GMP Cell Banking Services Market Size, by Stem Cells, 2017-2032 (USD Million)
TABLE 230. BRICS GMP Cell Banking Services Market Size, by Cell Bank Type, 2017-2032 (USD Million)
TABLE 231. BRICS GMP Cell Banking Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 232. BRICS GMP Cell Banking Services Market Size, by Biopharmaceutical Production, 2017-2032 (USD Million)
TABLE 233. BRICS GMP Cell Banking Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 234. G7 GMP Cell Banking Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 235. G7 GMP Cell Banking Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 236. G7 GMP Cell Banking Services Market Size, by Testing & Quality Control, 2017-2032 (USD Million)
TABLE 237. G7 GMP Cell Banking Services Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 238. G7 GMP Cell Banking Services Market Size, by Mammalian Cells, 2017-2032 (USD Million)
TABLE 239. G7 GMP Cell Banking Services Market Size, by Microbial Cells, 2017-2032 (USD Million)
TABLE 240. G7 GMP Cell Banking Services Market Size, by Stem Cells, 2017-2032 (USD Million)
TABLE 241. G7 GMP Cell Banking Services Market Size, by Cell Bank Type, 2017-2032 (USD Million)
TABLE 242. G7 GMP Cell Banking Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 243. G7 GMP Cell Banking Services Market Size, by Biopharmaceutical Production, 2017-2032 (USD Million)
TABLE 244. G7 GMP Cell Banking Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 245. NATO GMP Cell Banking Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 246. NATO GMP Cell Banking Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 247. NATO GMP Cell Banking Services Market Size, by Testing & Quality Control, 2017-2032 (USD Million)
TABLE 248. NATO GMP Cell Banking Services Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 249. NATO GMP Cell Banking Services Market Size, by Mammalian Cells, 2017-2032 (USD Million)
TABLE 250. NATO GMP Cell Banking Services Market Size, by Microbial Cells, 2017-2032 (USD Million)
TABLE 251. NATO GMP Cell Banking Services Market Size, by Stem Cells, 2017-2032 (USD Million)
TABLE 252. NATO GMP Cell Banking Services Market Size, by Cell Bank Type, 2017-2032 (USD Million)
TABLE 253. NATO GMP Cell Banking Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 254. NATO GMP Cell Banking Services Market Size, by Biopharmaceutical Production, 2017-2032 (USD Million)
TABLE 255. NATO GMP Cell Banking Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 256. Global GMP Cell Banking Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 257. United States GMP Cell Banking Services Market Size, 2017-2032 (USD Million)
TABLE 258. United States GMP Cell Banking Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 259. United States GMP Cell Banking Services Market Size, by Testing & Quality Control, 2017-2032 (USD Million)
TABLE 260. United States GMP Cell Banking Services Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 261. United States GMP Cell Banking Services Market Size, by Mammalian Cells, 2017-2032 (USD Million)
TABLE 262. United States GMP Cell Banking Services Market Size, by Microbial Cells, 2017-2032 (USD Million)
TABLE 263. United States GMP Cell Banking Services Market Size, by Stem Cells, 2017-2032 (USD Million)
TABLE 264. United States GMP Cell Banking Services Market Size, by Cell Bank Type, 2017-2032 (USD Million)
TABLE 265. United States GMP Cell Banking Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 266. United States GMP Cell Banking Services Market Size, by Biopharmaceutical Production, 2017-2032 (USD Million)
TABLE 267. United States GMP Cell Banking Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 268. Germany GMP Cell Banking Services Market Size, 2017-2032 (USD Million)
TABLE 269. Germany GMP Cell Banking Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 270. Germany GMP Cell Banking Services Market Size, by Testing & Quality Control, 2017-2032 (USD Million)
TABLE 271. Germany GMP Cell Banking Services Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 272. Germany GMP Cell Banking Services Market Size, by Mammalian Cells, 2017-2032 (USD Million)
TABLE 273. Germany GMP Cell Banking Services Market Size, by Microbial Cells, 2017-2032 (USD Million)
TABLE 274. Germany GMP Cell Banking Services Market Size, by Stem Cells, 2017-2032 (USD Million)
TABLE 275. Germany GMP Cell Banking Services Market Size, by Cell Bank Type, 2017-2032 (USD Million)
TABLE 276. Germany GMP Cell Banking Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 277. Germany GMP Cell Banking Services Market Size, by Biopharmaceutical Production, 2017-2032 (USD Million)
TABLE 278. Germany GMP Cell Banking Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 279. China GMP Cell Banking Services Market Size, 2017-2032 (USD Million)
TABLE 280. China GMP Cell Banking Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 281. China GMP Cell Banking Services Market Size, by Testing & Quality Control, 2017-2032 (USD Million)
TABLE 282. China GMP Cell Banking Services Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 283. China GMP Cell Banking Services Market Size, by Mammalian Cells, 2017-2032 (USD Million)
TABLE 284. China GMP Cell Banking Services Market Size, by Microbial Cells, 2017-2032 (USD Million)
TABLE 285. China GMP Cell Banking Services Market Size, by Stem Cells, 2017-2032 (USD Million)
TABLE 286. China GMP Cell Banking Services Market Size, by Cell Bank Type, 2017-2032 (USD Million)
TABLE 287. China GMP Cell Banking Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 288. China GMP Cell Banking Services Market Size, by Biopharmaceutical Production, 2017-2032 (USD Million)
TABLE 289. China GMP Cell Banking Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 290. India GMP Cell Banking Services Market Size, 2017-2032 (USD Million)
TABLE 291. India GMP Cell Banking Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 292. India GMP Cell Banking Services Market Size, by Testing & Quality Control, 2017-2032 (USD Million)
TABLE 293. India GMP Cell Banking Services Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 294. India GMP Cell Banking Services Market Size, by Mammalian Cells, 2017-2032 (USD Million)
TABLE 295. India GMP Cell Banking Services Market Size, by Microbial Cells, 2017-2032 (USD Million)
TABLE 296. India GMP Cell Banking Services Market Size, by Stem Cells, 2017-2032 (USD Million)
TABLE 297. India GMP Cell Banking Services Market Size, by Cell Bank Type, 2017-2032 (USD Million)
TABLE 298. India GMP Cell Banking Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 299. India GMP Cell Banking Services Market Size, by Biopharmaceutical Production, 2017-2032 (USD Million)
TABLE 300. India GMP Cell Banking Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 301. Japan GMP Cell Banking Services Market Size, 2017-2032 (USD Million)
TABLE 302. Japan GMP Cell Banking Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 303. Japan GMP Cell Banking Services Market Size, by Testing & Quality Control, 2017-2032 (USD Million)
TABLE 304. Japan GMP Cell Banking Services Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 305. Japan GMP Cell Banking Services Market Size, by Mammalian Cells, 2017-2032 (USD Million)
TABLE 306. Japan GMP Cell Banking Services Market Size, by Microbial Cells, 2017-2032 (USD Million)
TABLE 307. Japan GMP Cell Banking Services Market Size, by Stem Cells, 2017-2032 (USD Million)
TABLE 308. Japan GMP Cell Banking Services Market Size, by Cell Bank Type, 2017-2032 (USD Million)
TABLE 309. Japan GMP Cell Banking Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 310. Japan GMP Cell Banking Services Market Size, by Biopharmaceutical Production, 2017-2032 (USD Million)
TABLE 311. Japan GMP Cell Banking Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 312. United Kingdom GMP Cell Banking Services Market Size, 2017-2032 (USD Million)
TABLE 313. United Kingdom GMP Cell Banking Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 314. United Kingdom GMP Cell Banking Services Market Size, by Testing & Quality Control, 2017-2032 (USD Million)
TABLE 315. United Kingdom GMP Cell Banking Services Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 316. United Kingdom GMP Cell Banking Services Market Size, by Mammalian Cells, 2017-2032 (USD Million)
TABLE 317. United Kingdom GMP Cell Banking Services Market Size, by Microbial Cells, 2017-2032 (USD Million)
TABLE 318. United Kingdom GMP Cell Banking Services Market Size, by Stem Cells, 2017-2032 (USD Million)
TABLE 319. United Kingdom GMP Cell Banking Services Market Size, by Cell Bank Type, 2017-2032 (USD Million)
TABLE 320. United Kingdom GMP Cell Banking Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 321. United Kingdom GMP Cell Banking Services Market Size, by Biopharmaceutical Production, 2017-2032 (USD Million)
TABLE 322. United Kingdom GMP Cell Banking Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 323. Canada GMP Cell Banking Services Market Size, 2017-2032 (USD Million)
TABLE 324. Canada GMP Cell Banking Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 325. Canada GMP Cell Banking Services Market Size, by Testing & Quality Control, 2017-2032 (USD Million)
TABLE 326. Canada GMP Cell Banking Services Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 327. Canada GMP Cell Banking Services Market Size, by Mammalian Cells, 2017-2032 (USD Million)
TABLE 328. Canada GMP Cell Banking Services Market Size, by Microbial Cells, 2017-2032 (USD Million)
TABLE 329. Canada GMP Cell Banking Services Market Size, by Stem Cells, 2017-2032 (USD Million)
TABLE 330. Canada GMP Cell Banking Services Market Size, by Cell Bank Type, 2017-2032 (USD Million)
TABLE 331. Canada GMP Cell Banking Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 332. Canada GMP Cell Banking Services Market Size, by Biopharmaceutical Production, 2017-2032 (USD Million)
TABLE 333. Canada GMP Cell Banking Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 334. Russia GMP Cell Banking Services Market Size, 2017-2032 (USD Million)
TABLE 335. Russia GMP Cell Banking Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 336. Russia GMP Cell Banking Services Market Size, by Testing & Quality Control, 2017-2032 (USD Million)
TABLE 337. Russia GMP Cell Banking Services Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 338. Russia GMP Cell Banking Services Market Size, by Mammalian Cells, 2017-2032 (USD Million)
TABLE 339. Russia GMP Cell Banking Services Market Size, by Microbial Cells, 2017-2032 (USD Million)
TABLE

Companies Mentioned

  • 53Biologics
  • Austrianova
  • Cell Culture Company, LLC
  • Charles River Laboratories
  • Clean Cells
  • Eurofins Scientific Limited
  • ExcellGene SA
  • eXmoor pharma concepts ltd
  • Goodwin Biotechnology Inc.
  • Kaneka Eurogentec S.A.
  • Lonza Group Ltd.
  • Merck KGaA
  • NAOBIOS
  • OmniaBio
  • PackGene Biotech lnc.
  • ProBio Biotech Corporation
  • RoslinCT
  • SGS Group
  • SK pharmteco Inc.
  • Takara Bio Inc.
  • Texcell SA
  • uBriGene Biosciences International Co.
  • ViruSure GmbH
  • Wacker Chemie AG
  • WuXi Biologics

Related Topics

Related Reports

Cell Banking Outsourcing Market - Global Forecast 2026-2032 - Product Image

Cell Banking Outsourcing Market - Global Forecast 2026-2032

  • Report
  • 195 Pages
  • Global
From
GMP Cell Banking Services - Global Strategic Business Report - Product Image

GMP Cell Banking Services - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Cell Banking Outsourcing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Cell Banking Outsourcing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 130 Pages
  • Global
From
Cell Banking Outsourcing - Global Strategic Business Report - Product Image

Cell Banking Outsourcing - Global Strategic Business Report

  • Report
  • 366 Pages
  • Global
From
GMP Cell Banking Services Market Outlook 2026-2034: Market Share, and Growth Analysis - Product Image

GMP Cell Banking Services Market Outlook 2026-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From

About the GMP Cell Banking Services Market

GMP Cell Banking Services are an essential part of the drug discovery process. These services provide a secure and reliable source of cells for use in drug development. GMP Cell Banking Services involve the collection, storage, and distribution of cells for use in drug discovery and development. The cells are collected from a variety of sources, including human tissue, animal tissue, and cell lines. The cells are then stored in a secure environment, such as a laboratory or a cryogenic facility, and are monitored for quality and safety. The cells are then distributed to research laboratories and pharmaceutical companies for use in drug discovery and development. GMP Cell Banking Services are provided by a variety of companies, including ATCC, Cell Applications, Inc., CellGenix, Corning Life Sciences, and Lonza. These companies provide a range of services, including cell collection, storage, and distribution. They also provide quality assurance and regulatory compliance services to ensure the safety and efficacy of the cells used in drug discovery and development. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.